PL360096A1 - Zrekombinowana szczepionka wirusa ospy przeciw wirusowi zespołu rozmnażania i oddychania świni (PRRSV) - Google Patents

Zrekombinowana szczepionka wirusa ospy przeciw wirusowi zespołu rozmnażania i oddychania świni (PRRSV)

Info

Publication number
PL360096A1
PL360096A1 PL36009601A PL36009601A PL360096A1 PL 360096 A1 PL360096 A1 PL 360096A1 PL 36009601 A PL36009601 A PL 36009601A PL 36009601 A PL36009601 A PL 36009601A PL 360096 A1 PL360096 A1 PL 360096A1
Authority
PL
Poland
Prior art keywords
prrsv
vaccine
respiratory syndrome
syndrome virus
porcine reproductive
Prior art date
Application number
PL36009601A
Other languages
English (en)
Inventor
Jean-Christophe Francis Audonnet
Michel Joseph Marie Bublot
Jennifer Maria Perez
Philippe Guy Nicolas Baudu
Original Assignee
Merial
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial filed Critical Merial
Publication of PL360096A1 publication Critical patent/PL360096A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL36009601A 2000-05-24 2001-05-18 Zrekombinowana szczepionka wirusa ospy przeciw wirusowi zespołu rozmnażania i oddychania świni (PRRSV) PL360096A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20665500P 2000-05-24 2000-05-24
PCT/IB2001/000870 WO2001089559A2 (en) 2000-05-24 2001-05-18 Porcine reproductive and respiratory syndrome virus (prrsv) recombinant avipoxvirus vaccine

Publications (1)

Publication Number Publication Date
PL360096A1 true PL360096A1 (pl) 2004-09-06

Family

ID=22767352

Family Applications (1)

Application Number Title Priority Date Filing Date
PL36009601A PL360096A1 (pl) 2000-05-24 2001-05-18 Zrekombinowana szczepionka wirusa ospy przeciw wirusowi zespołu rozmnażania i oddychania świni (PRRSV)

Country Status (12)

Country Link
US (1) US20030003112A1 (pl)
EP (1) EP1283718A2 (pl)
JP (1) JP2003533989A (pl)
KR (1) KR20030036194A (pl)
CN (1) CN1443076A (pl)
AU (1) AU2001256582A1 (pl)
BR (1) BR0111366A (pl)
CA (1) CA2409874A1 (pl)
MX (1) MXPA02011545A (pl)
PL (1) PL360096A1 (pl)
WO (1) WO2001089559A2 (pl)
ZA (1) ZA200210230B (pl)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7628980B2 (en) 2000-11-23 2009-12-08 Bavarian Nordic A/S Modified vaccinia virus ankara for the vaccination of neonates
US7445924B2 (en) * 2000-11-23 2008-11-04 Bavarian Nordic A/S Modified Vaccinia Ankara virus variant and cultivation method
AU2002231639B2 (en) 2000-11-23 2007-01-04 Bavarian Nordic A/S Modified vaccinia ankara virus variant
CA2439254A1 (en) * 2001-03-09 2002-09-19 Boehringer Ingelheim Vetmedica Gmbh Life attenuated strains of prrs virus
US7276353B2 (en) * 2001-12-12 2007-10-02 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
US7279166B2 (en) 2001-12-12 2007-10-09 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
US7906311B2 (en) 2002-03-20 2011-03-15 Merial Limited Cotton rat lung cells for virus culture
EA011233B1 (ru) 2002-04-19 2009-02-27 Бавариан Нордик А/С Применение модифицированного вируса осповакцины анкара для вакцинации новорожденных
NZ538575A (en) 2002-09-05 2007-03-30 Bavarian Nordic As Method for the amplification of a virus wherein primary avian cells are cultivated in a serum-free medium comprising growth factors and attachment factors
DE602004015418D1 (de) * 2003-02-18 2008-09-11 Helmholtz Zentrum Muenchen Rekombinantes mva und verfahren zur erzeugung davon
JP2005075752A (ja) * 2003-08-29 2005-03-24 Nippon Inst For Biological Science 豚繁殖・呼吸障害症候群用ワクチン製剤
US7747980B2 (en) * 2004-06-08 2010-06-29 Covia Labs, Inc. Method and system for specifying device interoperability source specifying renditions data and code for interoperable device team
CA2571560C (en) 2004-06-25 2016-04-12 Merial Limited Avipox recombinants expressing foot and mouth disease virus genes
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
US8398994B2 (en) 2005-07-15 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Lawsonia vaccine and methods of use thereof
EP1792996A1 (en) * 2005-12-01 2007-06-06 Consejo Superior de Investigaciones Cientificas Nucleic acid sequences encoding vaccines against Porcine reproductive and respiratory syndrome virus (PRRSV)
US8470336B2 (en) 2006-05-25 2013-06-25 Boehringer Ingelheim Vetmedica, Inc. Vaccination of young animals against Lawsonia intracellularis infections
CA2687026A1 (en) * 2007-05-30 2009-03-05 Wyeth Raccoon poxvirus expressing genes of porcine virus
CL2008001806A1 (es) * 2007-06-20 2008-09-05 Wyeth Corp Composicion de vacuna en emulsion agua en aceite que comprende un antigeno y un adyuvante en la fase acuosa; y metodo de elaboracion.
US8398970B2 (en) 2007-09-17 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Method of preventing early Lawsonia intracellularis infections
KR101420850B1 (ko) * 2011-05-30 2014-08-13 건국대학교 산학협력단 돼지 생식기 호흡기 증후군 바이러스 유사입자 및 이를 이용한 백신
WO2012166493A1 (en) * 2011-06-01 2012-12-06 Merial Limited Needle-free administration of prrsv vaccines
WO2016021276A1 (ja) * 2014-08-08 2016-02-11 出光興産株式会社 豚繁殖・呼吸障害症候群防除剤
DE102015111756A1 (de) 2015-07-20 2017-01-26 Eberhard Karls Universität Tübingen Medizinische Fakultät Rekombinanter Orf-Virus-Vektor
CN107236824A (zh) * 2017-06-29 2017-10-10 新希望六和股份有限公司 一种用于猪繁殖与呼吸综合征病毒特异性检测的荧光定量rt‑pcr试剂盒及应用
CN115989030A (zh) * 2020-05-29 2023-04-18 康涅狄格大学 猪繁殖与呼吸综合征病毒的抑制剂
CN116333060B (zh) * 2023-05-15 2023-07-21 广州悦洋生物技术有限公司 猪繁殖与呼吸综合征病毒gp5蛋白及其制备方法和用途、基因、试剂盒和检测方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100242671B1 (ko) * 1991-03-07 2000-03-02 고돈 에릭 유전학적으로 처리한 백신 균주
GB2289279B (en) * 1994-05-13 1998-09-16 Iberica Cyanamid Diagnostic kits and vaccines containing recombinant PRRSV proteins
AU729518B2 (en) * 1995-06-07 2001-02-01 Syntro Corporation Recombinant fowlpox viruses and uses thereof
FR2775601B1 (fr) * 1998-03-03 2001-09-21 Merial Sas Vaccins vivants recombines et adjuves

Also Published As

Publication number Publication date
CN1443076A (zh) 2003-09-17
JP2003533989A (ja) 2003-11-18
WO2001089559A2 (en) 2001-11-29
AU2001256582A1 (en) 2001-12-03
ZA200210230B (en) 2003-10-27
KR20030036194A (ko) 2003-05-09
CA2409874A1 (en) 2001-11-29
BR0111366A (pt) 2003-05-20
EP1283718A2 (en) 2003-02-19
MXPA02011545A (es) 2003-06-06
US20030003112A1 (en) 2003-01-02
WO2001089559A3 (en) 2002-04-11

Similar Documents

Publication Publication Date Title
PL360096A1 (pl) Zrekombinowana szczepionka wirusa ospy przeciw wirusowi zespołu rozmnażania i oddychania świni (PRRSV)
AU7960598A (en) Recombinant porcine reproductive and respiratory syndrome virus (prrsv) for use as a vaccine
HK1029140A1 (en) Infectious cdna clone or north american porcine reproductive and respiratory syndrome (prrs)virus and uses thereof.
AU4932601A (en) Recombinant parainfluenza virus expression systems and vaccines
HU9602421D0 (en) Para-influenza virus-containing vaccines for preventing porcine reproductive and respiratory syndrome
PL1951882T3 (pl) Kwasy nukleinowe kodujące szczepionkę przeciwko wirusowi wywołującemu zespół zaburzeń reprodukcyjnych i oddechowych u świń
DK1058558T3 (da) Rekombinante og adjuverede vacciner mod influenzavirus og herpesvirus
AU3512797A (en) Porcine reproductive and respiratory syndrome vaccine
IL223344A (en) Adno recombinant virus with a shell containing the hexane protein adpan6 and its uses
LU91326I2 (fr) Vaccin papillomavirus humain Ä6,11,16,18Ü(recombinant, adsorbé)
HUP9801124A3 (en) New attenuated strain of the virus causing the porcine reproductive respiratory syndrome (prrs), vaccines and diagnostic means obtainable with said strain, and production process
DE69839169D1 (de) Aus infektiöser cDNA gewonnene rekombinate YF Viren-Impfstoffe
EP1305438A4 (en) IMPROVED VIRUS-SIMILAR PARTICLES BUILDING ON THE HEPATITIS B SMALL SLEEP PROTEIN
ZA971663B (en) Porcine reproductive and respiratory syndrome vaccine.
IL158428A0 (en) Vaccine composition comprising at least one hiv virus antigen
IL131212A0 (en) Recombinant virus and live-virus vaccines
EP1749885B8 (en) Infectious and attenuated bovine viral diarrhea virus vaccine
AU2001246331A1 (en) Hepatitis b virus (hbv) antigenic polypeptide-heat shock protein complex and use thereof
EP1399481A4 (en) RECOMBINANT ANTIBODIES TO INFECTIOUS BURSAL DISEASE VIRUS (IBDV)
EP1204424A4 (en) VACCINES AND RECOMBINANT RS VIRUS EXPRESSION SYSTEMS
EP1389043A4 (en) VACCINE AGAINST THE MOUSE AND CLAUS ACID VIRUS
ZA200703762B (en) Mutant porcine reproductive and respiratory syndrome virus
SG83740A1 (en) An attenuated porcine reproductive and respiratory syndrome virus strain and methods of use
EP1296710A4 (en) RECOMBINANT VACCINES AGAINST INFECTIOUS BURSITY VIRUS
EP1490396A4 (en) IMMUNOGENIC HIV PEPTIDES AS REAGENTS AND AS VACCINES

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)